Scinovex
articleTop 1% cited

Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer

Clinical Cancer Research · 2008 · Vol. 14(14) · pp. 4491–4499
Navneet K. DhillonBharat B. AggarwalRobert A. NewmanRobert A. WolffAjaikumar B. KunnumakkaraJames L. AbbruzzeseChaan S. NgVladimir BadmaevRazelle Kurzrock

Abstract

Oral curcumin is well tolerated and, despite its limited absorption, has biological activity in some patients with pancreatic cancer.

Curcumin's Biomedical ApplicationsRetinoids in leukemia and cellular processesNF-κB Signaling PathwaysCurcuminMedicinePancreatic cancerCytokinePeripheral blood mononuclear cellPharmacologyGemcitabinePancreatic diseaseInternal medicineCancer

MeSH terms

Electrophoretic Mobility Shift AssayAdenocarcinomaAdultAgedAntineoplastic AgentsCurcuminFemaleHumansImmunohistochemistryMaleMiddle AgedPancreatic NeoplasmsCytokinesNF-kappa BCyclooxygenase 2
Citations
1,303
FWCI
26.33
field-weighted impact
References
37
Percentile
100%
vs. same field & year
Citations per year
Cited by
Role of nano-curcumin: A treatment for cancer
Journal of Medicinal Plants Studies · 2017 · 6 citations
Curcumin and Cancer
Nutrients · 2019 · 965 citations
The Essential Medicinal Chemistry of Curcumin
Journal of Medicinal Chemistry · 2017 · 1,824 citations
A Review of Curcumin and Its Derivatives as Anticancer Agents
International Journal of Molecular Sciences · 2019 · 909 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.